{"id":"iv-insulin-infusion","safety":{"commonSideEffects":[{"rate":"variable, dose-dependent","effect":"Hypoglycemia"},{"rate":"common with IV infusion","effect":"Hypokalemia"},{"rate":null,"effect":"Local injection site reactions"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Insulin is a peptide hormone that activates the insulin receptor, a transmembrane tyrosine kinase receptor. This triggers intracellular signaling cascades that increase glucose transport into muscle and adipose tissue, promote glycogen synthesis, and inhibit gluconeogenesis, thereby reducing hyperglycemia. IV infusion allows rapid onset and precise titration of blood glucose control in acute care settings.","oneSentence":"Insulin binds to insulin receptors on cells to promote glucose uptake and utilization, lowering blood glucose levels.","_ai_confidence":"high"},"_scrapedAt":"2026-03-27T23:50:33.778Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Hyperglycemia in hospitalized patients"},{"name":"Diabetic ketoacidosis"},{"name":"Hyperglycemic hyperosmolar state"}]},"trialDetails":[{"nctId":"NCT07485101","phase":"NA","title":"Glycemic Targets During CPB in Elderly Diabetes","status":"NOT_YET_RECRUITING","sponsor":"Beijing Anzhen Hospital","startDate":"2026-04-01","conditions":"Glycemic Management During CPB in Elderly Diabetic Cardiac Surgery","enrollment":3000},{"nctId":"NCT06872333","phase":"PHASE2","title":"Allo HSCT for High Risk Hemoglobinopathies","status":"RECRUITING","sponsor":"Masonic Cancer Center, University of Minnesota","startDate":"2024-11-19","conditions":"Graft Failure, Sickle Cell Disease, Hemoglobinopathies","enrollment":62},{"nctId":"NCT07451561","phase":"NA","title":"Role of Combination Therapy of Glucose Insulin Potassium Infusion (GIK), Intravenous Hydrocortisone and Oral Sevelamer in Treatment of Acute Aluminum Phosphide Poisoned Cases Admitted to Intensive Care Unit (ICU) at Sohag University Hospitals.","status":"NOT_YET_RECRUITING","sponsor":"Sohag University","startDate":"2026-03","conditions":"Acute Aluminum Phosphide Poisoned Cases","enrollment":74},{"nctId":"NCT06624956","phase":"PHASE4","title":"Prevention and Treatment of Common Hyperglycemia in Surgery Pilot","status":"COMPLETED","sponsor":"University of Washington","startDate":"2024-09-04","conditions":"Surgery, Non Diabetic Hyperglycemia","enrollment":106},{"nctId":"NCT06111586","phase":"PHASE2","title":"FrexalimAB in Preservation of Endogenous insULIN Secretion Compared to Placebo in adUlts and Adolescents on Top of inSulin Therapy (FABULINUS)","status":"RECRUITING","sponsor":"Sanofi","startDate":"2023-12-11","conditions":"Type 1 Diabetes Mellitus","enrollment":192},{"nctId":"NCT07167693","phase":"PHASE1, PHASE2","title":"Phase 1 Trial of Arginine Hydrochloride for the Management of Diabetic Ketoacidosis in Type 2 Diabetes","status":"RECRUITING","sponsor":"David K Carroll","startDate":"2025-12-19","conditions":"Diabetes (DM), Diabetic Ketoacidosis, Ketosis Prone Diabetes","enrollment":60},{"nctId":"NCT06883344","phase":"NA","title":"Automated Insulin for Management of Intrapartum Glycemia","status":"RECRUITING","sponsor":"University of California, San Francisco","startDate":"2025-12-05","conditions":"Type 1 Diabetes (T1D), Pregnancy, Pre-Gestational Diabetes","enrollment":150},{"nctId":"NCT07224334","phase":"PHASE1","title":"Role of Alpha-to-beta Cell Communication to Adapt Insulin Secretion to Insulin Resistance.","status":"RECRUITING","sponsor":"David D'Alessio, M.D.","startDate":"2025-12-30","conditions":"Diabetes (DM)","enrollment":30},{"nctId":"NCT07359625","phase":"NA","title":"Effects of Ketone Bodies on Insulin Sensitivity","status":"RECRUITING","sponsor":"University of Aarhus","startDate":"2025-12-02","conditions":"Insulin Resistance, Obesity & Overweight, Energy Metabolism","enrollment":10},{"nctId":"NCT07326865","phase":"NA","title":"Hepatic Gene Response to Intravenous Glucose in Obese Patients With and Without MASLD Undergoing Bariatric Surgery","status":"RECRUITING","sponsor":"Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)","startDate":"2025-11-12","conditions":"MASLD","enrollment":40},{"nctId":"NCT03253263","phase":"PHASE2","title":"A Clinical Efficacy and Safety Study of OHB-607 in Preventing Bronchopulmonary Dysplasia in Extremely Premature Infants","status":"RECRUITING","sponsor":"OHB Neonatology Ltd.","startDate":"2019-05-09","conditions":"Bronchopulmonary Dysplasia, Chronic Lung Disease of Prematurity, Intraventricular Hemorrhage","enrollment":338},{"nctId":"NCT07300982","phase":"PHASE1, PHASE2","title":"Studies of Insulin and Glucagon Action in the Liver","status":"NOT_YET_RECRUITING","sponsor":"Duke University","startDate":"2026-04","conditions":"Diabetes (DM)","enrollment":40},{"nctId":"NCT05389514","phase":"","title":"Intermediate-size IND for Treatment of KRAS G12V-mutant Tumors","status":"TEMPORARILY_NOT_AVAILABLE","sponsor":"Providence Health & Services","startDate":"","conditions":"KRAS G12V Mutant Advanced Epithelial Cancers","enrollment":""},{"nctId":"NCT06090864","phase":"PHASE1, PHASE2","title":"ATLCAR.CD30.CCR4 for CD30+ HL ATLCAR.CD30.CCR4 Cells","status":"RECRUITING","sponsor":"UNC Lineberger Comprehensive Cancer Center","startDate":"2024-04-25","conditions":"Hodgkin Lymphoma, Relapse, Refractory","enrollment":31},{"nctId":"NCT06548100","phase":"PHASE3","title":"A Study of the Safety of Mibavademab in Pediatric and Adult Participants Switching From Metreleptin to Mibavademab for the Treatment of Generalized Lipodystrophy (GLD)","status":"ACTIVE_NOT_RECRUITING","sponsor":"Regeneron Pharmaceuticals","startDate":"2024-12-16","conditions":"Generalized Lipodystrophy","enrollment":9},{"nctId":"NCT01803451","phase":"EARLY_PHASE1","title":"Glucagon-like Peptide 1, Glucose Metabolism and Gastric Bypass","status":"RECRUITING","sponsor":"The University of Texas Health Science Center at San Antonio","startDate":"2005-11","conditions":"Post-bariatric Surgery","enrollment":80},{"nctId":"NCT02244073","phase":"NA","title":"Individualized Blood Glucose Control in ICU. The CONTROLING Study. A Double Blinded Multicentric Randomized Study.","status":"TERMINATED","sponsor":"Hospices Civils de Lyon","startDate":"2015-05","conditions":"Critical Illness","enrollment":2069},{"nctId":"NCT02054429","phase":"PHASE1","title":"Intensive Insulin Therapy With Tight Glycemic Control to Improve Outcomes After Endovascular Therapy for Acute Ischemic Stroke","status":"COMPLETED","sponsor":"University at Buffalo","startDate":"2013-01","conditions":"Ischemic Stroke","enrollment":30},{"nctId":"NCT03241706","phase":"PHASE1","title":"Liver Glycogen and Hypoglycemia in Humans","status":"ACTIVE_NOT_RECRUITING","sponsor":"Jason Winnick","startDate":"2018-08-02","conditions":"Hypoglycemia; Iatrogenic","enrollment":40},{"nctId":"NCT02103283","phase":"PHASE1","title":"A Phase 1, Open-Label Study of Teprotumumab in Patients With Diabetic Macular Edema (DME)","status":"COMPLETED","sponsor":"Amgen","startDate":"2014-10","conditions":"Diabetic Macular Edema","enrollment":5},{"nctId":"NCT06412497","phase":"PHASE2","title":"MT2023-20: Hematopoietic Cell Transplant With Reduced Intensity Conditioning and Post-transplant Cyclophosphamide for Severe Aplastic Anemia and Other Forms of Acquired Bone Marrow Failure.","status":"RECRUITING","sponsor":"Masonic Cancer Center, University of Minnesota","startDate":"2024-06-05","conditions":"Severe Aplastic Anemia, Acquired Amegakaryocytic Thrombocytopenia, Acquired Pure Red Cell Aplasia","enrollment":60},{"nctId":"NCT03912363","phase":"NA","title":"Intrapartum Glycemic Control With Insulin Infusion Versus Rotating Fluids","status":"COMPLETED","sponsor":"Geisinger Clinic","startDate":"2019-11-01","conditions":"Type II Diabetes Mellitus, Gestational Diabetes Mellitus","enrollment":114},{"nctId":"NCT01528189","phase":"NA","title":"Effect of High Dose Insulin on Infectious Complications Following Major Surgery","status":"RECRUITING","sponsor":"McGill University Health Centre/Research Institute of the McGill University Health Centre","startDate":"2018-10-05","conditions":"Surgical Site Infection After Major Surgery","enrollment":460},{"nctId":"NCT06105931","phase":"PHASE1","title":"Physiologic Markers of Cardiometabolic Risk in People With Type 1 Diabetes","status":"RECRUITING","sponsor":"Yale University","startDate":"2023-12-13","conditions":"type1diabetes, Obesity","enrollment":15},{"nctId":"NCT06424652","phase":"NA","title":"Effect of Physiologic Insulin Administration on Cognition","status":"COMPLETED","sponsor":"Pennington Biomedical Research Center","startDate":"2024-05-16","conditions":"Alzheimer Disease","enrollment":1},{"nctId":"NCT05419115","phase":"PHASE2","title":"Use of a Novel SUBCUTaneous Preparation of Furosemide to Facilitate Early Supported Discharge of Patients With Heart Failure","status":"RECRUITING","sponsor":"NHS Greater Glasgow and Clyde","startDate":"2022-11-17","conditions":"Heart Failure","enrollment":170},{"nctId":"NCT00179400","phase":"PHASE4","title":"The Role of Acute Combined PPAR Alpha and Gamma Stimulation on Insulin Action in Humans","status":"COMPLETED","sponsor":"Albert Einstein College of Medicine","startDate":"2000-12","conditions":"Type 2 Diabetes Mellitus","enrollment":26},{"nctId":"NCT01868997","phase":"PHASE2","title":"Teprotumumab (RV 001) Treatment in Patients With Active Thyroid Eye Disease","status":"COMPLETED","sponsor":"Amgen","startDate":"2013-07","conditions":"Thyroid Associated Ophthalmopathies, Thyroid-Associated Ophthalmopathy","enrollment":88},{"nctId":"NCT06126419","phase":"NA","title":"Application of High-dose Insulin Therapy to Improve Liver Function and Regeneration","status":"RECRUITING","sponsor":"McGill University Health Centre/Research Institute of the McGill University Health Centre","startDate":"2023-11-08","conditions":"Liver Dysfunction, Liver Metastasis Colon Cancer, Liver Regeneration","enrollment":70},{"nctId":"NCT03660189","phase":"NA","title":"Two Bag System for Diabetic Ketoacidosis","status":"TERMINATED","sponsor":"MetroHealth Medical Center","startDate":"2018-09-17","conditions":"Diabetic Ketoacidosis","enrollment":57},{"nctId":"NCT04532801","phase":"PHASE1","title":"Evaluation of Kisspeptin Glucose-Stimulated Insulin Secretion With Physiologic Mixed Meal Tolerance","status":"WITHDRAWN","sponsor":"Stephanie B. Seminara, MD","startDate":"2019-09-01","conditions":"Insulin, Glucose, Healthy Volunteers","enrollment":""},{"nctId":"NCT06126354","phase":"PHASE1","title":"Dexamethasone/Pancreatic Clamp P&F","status":"WITHDRAWN","sponsor":"Columbia University","startDate":"2024-07-01","conditions":"Insulin Resistance, Prediabetic State, Non-Alcoholic Fatty Liver Disease","enrollment":""},{"nctId":"NCT04599075","phase":"PHASE4","title":"Intravenous Insulin vs Subcutaneous Insulin Infusion in Intrapartum Management of Type 1 Diabetes Mellitus","status":"COMPLETED","sponsor":"Gianna Wilkie","startDate":"2021-03-15","conditions":"Type 1 Diabetes, Pregnancy, High Risk","enrollment":70},{"nctId":"NCT06007508","phase":"PHASE2","title":"Early Administration of Insulin Glargine in Patients With Diabetic Ketoacidosis","status":"TERMINATED","sponsor":"HealthPartners Institute","startDate":"2022-05-31","conditions":"DKA","enrollment":8},{"nctId":"NCT03175978","phase":"PHASE1, PHASE2","title":"IGF-MTX Conjugate in the Treatment of Myelodysplastic Syndrome","status":"TERMINATED","sponsor":"IGF Oncology, LLC","startDate":"2018-02-21","conditions":"Myelodysplastic Syndromes, Leukemia, Myelomonocytic, Chronic, Anemia, Refractory, With Excess of Blasts","enrollment":2},{"nctId":"NCT04946552","phase":"NA","title":"Sympathetic Activation in Obesity","status":"COMPLETED","sponsor":"Yale University","startDate":"2021-11-23","conditions":"Obesity, Healthy","enrollment":5},{"nctId":"NCT06176599","phase":"NA","title":"Clinical Study on the Treatment of Diabetic Kidney Disease With Shenxiao Yuning Decoction With Syndrome of Qi and Yin Deficiency and Blood Stasis","status":"UNKNOWN","sponsor":"Lin Liao","startDate":"2022-09-01","conditions":"Diabetic Kidney Disease","enrollment":60},{"nctId":"NCT06116188","phase":"","title":"Brain Insulin Resistance in Mild Cognitive Impairment","status":"UNKNOWN","sponsor":"Turku University Hospital","startDate":"2023-10-12","conditions":"Alzheimer Disease, Mild Cognitive Impairment, Positron Emission Tomography","enrollment":40},{"nctId":"NCT00858897","phase":"NA","title":"Glutathione Metabolism in Adolescents With Type 1 Diabetes - Study A","status":"COMPLETED","sponsor":"Nemours Children's Clinic","startDate":"2007-06","conditions":"Diabetes Mellitus, Type 1","enrollment":10},{"nctId":"NCT00673309","phase":"PHASE2, PHASE3","title":"Assessment of Mechanisms of Improved Wound Healing","status":"COMPLETED","sponsor":"The University of Texas Medical Branch, Galveston","startDate":"2000-07","conditions":"Burns","enrollment":644},{"nctId":"NCT02032953","phase":"PHASE4","title":"Enhancing the Anabolic Effect of Perioperative Nutrition With Insulin While Maintaining Normoglycemia","status":"UNKNOWN","sponsor":"McGill University Health Centre/Research Institute of the McGill University Health Centre","startDate":"2013-12","conditions":"Colorectal Cancer","enrollment":24},{"nctId":"NCT02102243","phase":"PHASE4","title":"Neural Mechanism of Aldosterone-induced Insulin Resistance","status":"WITHDRAWN","sponsor":"Wanpen Vongpatanasin","startDate":"2010-11","conditions":"Hypertension","enrollment":""},{"nctId":"NCT03195400","phase":"","title":"Pathogenesis of Youth Onset Type 2 Diabetes and Prediabetes","status":"COMPLETED","sponsor":"Yale University","startDate":"2017-03-01","conditions":"IGT - Impaired Glucose Tolerance, T2D","enrollment":100},{"nctId":"NCT04567225","phase":"PHASE4","title":"Early Basal Insulin Administration in Adult Diabetic Ketoacidosis Management","status":"TERMINATED","sponsor":"The Cleveland Clinic","startDate":"2020-10-01","conditions":"Diabetic Ketoacidosis, Type 1 Diabetes, Type 2 Diabetes","enrollment":39},{"nctId":"NCT02930044","phase":"NA","title":"Early Subcutaneous Insulin Glargine Plus Standard of Care for Treatment of Diabetic Ketoacidosis","status":"COMPLETED","sponsor":"University of Maryland, Baltimore","startDate":"2016-10","conditions":"Diabetic Ketoacidosis","enrollment":18},{"nctId":"NCT00214916","phase":"PHASE2","title":"Tight Glycemic Control With Intensive Insulin Therapy in PICU","status":"UNKNOWN","sponsor":"Greet Van den Berghe","startDate":"2004-10","conditions":"Critical Illness","enrollment":700},{"nctId":"NCT05155917","phase":"PHASE2","title":"Concurrent Subcutaneous Basal Insulin and Intravenous Insulin Pump in Hyperglycemic Crisis Patients Under Critical Care","status":"UNKNOWN","sponsor":"Changhua Christian Hospital","startDate":"2022-03-01","conditions":"Hyperglycaemic Crisis in Diabetes Mellitus, Diabetic Ketoacidosis, Hyperglycaemic Hyperosmolar Nonketotic Syndrome","enrollment":70},{"nctId":"NCT00882050","phase":"PHASE1, PHASE2","title":"Intravenous Exenatide (Byetta) During Surgery","status":"COMPLETED","sponsor":"Thomas Jefferson University","startDate":"2009-03","conditions":"Euglycemia, Hypoglycemia, Hyperglycemia","enrollment":104},{"nctId":"NCT02936687","phase":"PHASE1","title":"Mechanisms of Cerebrovascular Control","status":"COMPLETED","sponsor":"University of Wisconsin, Madison","startDate":"2017-01-31","conditions":"Metabolic Syndrome X","enrollment":59},{"nctId":"NCT01096784","phase":"PHASE2","title":"IGF-1/IGFBP3 Prevention of Retinopathy of Prematurity","status":"COMPLETED","sponsor":"Shire","startDate":"2010-06-18","conditions":"Retinopathy of Prematurity (ROP)","enrollment":121},{"nctId":"NCT03028571","phase":"PHASE1","title":"Autonomic Blockade and Endogenous Glucose Production","status":"WITHDRAWN","sponsor":"Vanderbilt University Medical Center","startDate":"2017-04-17","conditions":"Insulin Resistance","enrollment":""},{"nctId":"NCT01327612","phase":"PHASE2","title":"Open Label Extension Study of Conatumumab and Ganitumab (AMG 479)","status":"COMPLETED","sponsor":"Amgen","startDate":"2011-03-03","conditions":"Advanced Solid Tumors, Carcinoid, Colorectal Cancer","enrollment":12},{"nctId":"NCT00642941","phase":"PHASE2","title":"A Study of R1507 in Participants With Recurrent or Refractory Sarcoma","status":"TERMINATED","sponsor":"Hoffmann-La Roche","startDate":"2007-12-18","conditions":"Sarcoma","enrollment":317},{"nctId":"NCT04712266","phase":"EARLY_PHASE1","title":"A Trial to Investigate Hyperglycemic and Hypoglycemic Excursions in Subjects With Type 1 Diabetes","status":"COMPLETED","sponsor":"Abvance Therapeutics","startDate":"2020-09-15","conditions":"Type 1 Diabetes Mellitus With Hypoglycemia","enrollment":15},{"nctId":"NCT04299815","phase":"NA","title":"Lactate in the Gut","status":"COMPLETED","sponsor":"University of Aarhus","startDate":"2020-04-01","conditions":"Lactate, Healthy, Hyperlactatemia","enrollment":10},{"nctId":"NCT02548494","phase":"NA","title":"Early Administration of Long-acting Insulin Treatment of Diabetic Ketoacidosis in Pediatric Type 1 Diabetes","status":"TERMINATED","sponsor":"Chattanooga-Hamilton County Hospital Authority","startDate":"2015-11","conditions":"Diabetes Mellitus, Type 1, Diabetic Ketoacidosis","enrollment":17},{"nctId":"NCT03330314","phase":"PHASE1","title":"Molar Potency Study of HM12460A in Healthy Subjects","status":"COMPLETED","sponsor":"Hanmi Pharmaceutical Company Limited","startDate":"2017-10-24","conditions":"Healthy Volunteers","enrollment":38},{"nctId":"NCT02398383","phase":"EARLY_PHASE1","title":"Role of Glucagon In Glucose Control in Cystic Fibrosis Related Diabetes","status":"COMPLETED","sponsor":"Yale University","startDate":"2015-03","conditions":"Cystic Fibrosis, Cystic Fibrosis Related Diabetes","enrollment":7},{"nctId":"NCT03234751","phase":"PHASE1","title":"Effect of Nesiritide Infusion on Insulin Sensitivity in Healthy Obese Insulin Resistant Subjects","status":"COMPLETED","sponsor":"AdventHealth Translational Research Institute","startDate":"2017-07-13","conditions":"Diabetes","enrollment":6},{"nctId":"NCT02206152","phase":"PHASE1, PHASE2","title":"A Randomized Double Blinded Study to Examine the Use of N-acetyl Cysteine for the Prevention and Treatment of HAAF in Patients With Type 1 Diabetes","status":"COMPLETED","sponsor":"University of Minnesota","startDate":"2015-02","conditions":"Type 1 Diabetes, Hypoglycemia Unawareness","enrollment":22},{"nctId":"NCT02556918","phase":"PHASE4","title":"Sitagliptin for Hyperglycemia in Patients With T2DM Undergoing Cardiac Surgery","status":"COMPLETED","sponsor":"Emory University","startDate":"2016-01","conditions":"Hyperglycemia","enrollment":202},{"nctId":"NCT03170544","phase":"PHASE1","title":"Single Ascending Dose Study of MK-1092 in Healthy Participants and in Participants With Type 1 and Type 2 Diabetes Mellitus (MK-1092-001)","status":"COMPLETED","sponsor":"Merck Sharp & Dohme LLC","startDate":"2017-08-16","conditions":"Type 1 Diabetes Mellitus, Type 2 Diabetes Mellitus","enrollment":69},{"nctId":"NCT02321111","phase":"PHASE2","title":"The Role of TLR4 on Lipid-induced Insulin Resistance","status":"COMPLETED","sponsor":"The University of Texas Health Science Center at San Antonio","startDate":"2015-01","conditions":"Insulin Sensitivity","enrollment":10},{"nctId":"NCT03461510","phase":"NA","title":"Type 2 Diabetes and the Brain in Adolescents","status":"COMPLETED","sponsor":"Nemours Children's Clinic","startDate":"2017-12-05","conditions":"Type 2 Diabetes Mellitus, Obesity, Pediatric Obesity","enrollment":18},{"nctId":"NCT03520153","phase":"","title":"Characterization of Diabetes Mellitus in Fibrous Dysplasia/McCune-Albright Syndrome","status":"WITHDRAWN","sponsor":"Yale University","startDate":"2018-08-07","conditions":"McCune-Albright Syndrome, Fibrous Dysplasia, Intraductal Papillary Mucinous Neoplasm","enrollment":""},{"nctId":"NCT02045368","phase":"PHASE1","title":"Study of Insulin-like Growth Factor (IGF)-Methotrexate Conjugate in the Treatment of Advanced Tumors Expressing IGF-1R","status":"COMPLETED","sponsor":"IGF Oncology, LLC","startDate":"2014-01-28","conditions":"Breast Cancer, Brain Cancer, Gastrointestinal Cancers","enrollment":92},{"nctId":"NCT02109029","phase":"PHASE1","title":"A Study of LY2605541 (Insulin Peglispro) and Human Insulin Concentrations in Fat Tissue","status":"COMPLETED","sponsor":"Eli Lilly and Company","startDate":"2014-04","conditions":"Diabetes Mellitus, Type 1","enrollment":24},{"nctId":"NCT00816361","phase":"PHASE1","title":"A Dose-escalation Study to Evaluate the Safety, Tolerability, and Antitumor Activity of MEDI-573 in Subjects With Advanced Solid Tumors","status":"COMPLETED","sponsor":"MedImmune LLC","startDate":"2009-03-09","conditions":"Cancer","enrollment":43},{"nctId":"NCT01498952","phase":"PHASE1","title":"MEDI-573 in Combination With SOC in Unresectable or Metastatic HCC.","status":"COMPLETED","sponsor":"MedImmune LLC","startDate":"2012-01-17","conditions":"Unresectable or Metastatic Hepatocellular Carcinoma (HCC)","enrollment":6},{"nctId":"NCT02406586","phase":"NA","title":"Free Fatty Acids-Induced Hypertension in Obese Subjects (Aim #2)","status":"COMPLETED","sponsor":"Emory University","startDate":"2009-07","conditions":"Hypertension, Diabetes","enrollment":36},{"nctId":"NCT00394524","phase":"NA","title":"Trial Between a Computer-Guided Insulin Infusion Protocol Versus a Standard Insulin Infusion Algorithm in Medical ICU","status":"COMPLETED","sponsor":"Emory University","startDate":"2006-06","conditions":"Diabetes or With New Hyperglycemia","enrollment":160},{"nctId":"NCT01183468","phase":"PHASE1","title":"A Research Trial of Aralast in New Onset Diabetes (RETAIN)","status":"TERMINATED","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"2010-10","conditions":"Diabetes Mellitus, Type 1","enrollment":17},{"nctId":"NCT01474785","phase":"PHASE1","title":"RYGB and the Gastric Adipose Axis","status":"COMPLETED","sponsor":"Vanderbilt University","startDate":"2012-01","conditions":"Obesity","enrollment":49},{"nctId":"NCT02370745","phase":"NA","title":"Characterizing the Incretin Effect of Amino Acids and Defining GLP-1 Role on Skeletal Muscle","status":"COMPLETED","sponsor":"University of Nottingham","startDate":"2014-11","conditions":"Sarcopenia","enrollment":40},{"nctId":"NCT03458715","phase":"PHASE4","title":"The Efficacy of Sodium-glucose Co-transporter 2 Inhibitor or Dipeptidyl Peptidase-4 Inhibitor in Type 2 Diabetes Patients With Premix Insulin","status":"UNKNOWN","sponsor":"Mackay Memorial Hospital","startDate":"2017-09-21","conditions":"Type2 Diabetes","enrollment":120},{"nctId":"NCT02443402","phase":"PHASE4","title":"Sitagliptin in Non-Diabetic Patients Undergoing Cardiac Surgery","status":"COMPLETED","sponsor":"Emory University","startDate":"2016-01","conditions":"Coronary Artery Disease","enrollment":68},{"nctId":"NCT02982551","phase":"EARLY_PHASE1","title":"Insulin Modulation of fMRI Connectivity in Healthy Adults","status":"WITHDRAWN","sponsor":"University of Pittsburgh","startDate":"2016-01-01","conditions":"Healthy Volunteers","enrollment":""},{"nctId":"NCT03330327","phase":"PHASE1","title":"Molar Potency Study of HM12470 in Healthy Subjects","status":"COMPLETED","sponsor":"Hanmi Pharmaceutical Company Limited","startDate":"2015-03-30","conditions":"Healthy Subjects","enrollment":56},{"nctId":"NCT01162499","phase":"NA","title":"Role of Glucagon-Like Peptide-1 in Postprandial Hypoglycemia","status":"COMPLETED","sponsor":"Diva De Leon","startDate":"2010-04","conditions":"Postprandial Hypoglycemia","enrollment":7},{"nctId":"NCT02516150","phase":"PHASE4","title":"Effect of Ethanol Intoxication on the Anti-Hypoglycemic Action of Glucagon","status":"COMPLETED","sponsor":"Massachusetts General Hospital","startDate":"2016-03","conditions":"Type 1 Diabetes Mellitus","enrollment":26},{"nctId":"NCT02746432","phase":"PHASE4","title":"Insulin Therapy Reduce Post-Operative Inflammatory Response After Curative Colorectal Cancer Resection: Randomization Controlled Trial","status":"UNKNOWN","sponsor":"King Saud University","startDate":"2018-01-01","conditions":"Colon Cancer","enrollment":144},{"nctId":"NCT00813605","phase":"PHASE2","title":"QUILT-2.018: Safety & Efficacy of FOLFIRI With AMG 479 or AMG 655 vs FOLFIRI Alone in KRAS-mutant Metastatic Colorectal Carcinoma","status":"COMPLETED","sponsor":"NantCell, Inc.","startDate":"2009-03","conditions":"Metastatic Colorectal Cancer","enrollment":155},{"nctId":"NCT01916733","phase":"","title":"A Quality Initiative to Improve Glycemic Control in Diabetic and Non-Diabetic Insulin Study","status":"COMPLETED","sponsor":"University of Vermont Medical Center","startDate":"2013-01","conditions":"Glycemic Control, Surgical Site Infections, Cardiac Complications","enrollment":89},{"nctId":"NCT00580957","phase":"NA","title":"The Autonomic Nervous System and the Metabolic Syndrome","status":"COMPLETED","sponsor":"Vanderbilt University","startDate":"2008-08","conditions":"Obesity","enrollment":56},{"nctId":"NCT00468403","phase":"PHASE2","title":"LEA29Y (Belatacept) Emory Edmonton Protocol","status":"COMPLETED","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"2008-10","conditions":"Type 1 Diabetes Mellitus","enrollment":10},{"nctId":"NCT01483651","phase":"NA","title":"Physiologic Response to Glucagon at Varying Insulin Levels","status":"COMPLETED","sponsor":"Legacy Health System","startDate":"2011-11","conditions":"Type 1 Diabetes Mellitus","enrollment":11},{"nctId":"NCT02697305","phase":"NA","title":"Incretin Effects of Branched Chain Amino Acids","status":"COMPLETED","sponsor":"Charles University, Czech Republic","startDate":"2014-09","conditions":"Glucose Metabolism Disorders","enrollment":18},{"nctId":"NCT01744236","phase":"PHASE4","title":"SAFEGUARD: Pleiotropic Effects of Incretin Based Therapies","status":"COMPLETED","sponsor":"Amsterdam UMC, location VUmc","startDate":"2013-04","conditions":"Type 2 Diabetes","enrollment":70},{"nctId":"NCT02272296","phase":"PHASE4","title":"Reliability of Insulin by Jet Injection","status":"COMPLETED","sponsor":"Radboud University Medical Center","startDate":"2015-02","conditions":"Diabetes Mellitus","enrollment":30},{"nctId":"NCT02012166","phase":"PHASE1","title":"A Study of MK-0893 on Glucagon-Induced Glycemic Excursion in Healthy Male Participants Following Intravenous Administration of Glucagon, Sandostatine® and Insulin (MK-0893-002)","status":"COMPLETED","sponsor":"Merck Sharp & Dohme LLC","startDate":"2005-07","conditions":"Type 2 Diabetes Mellitus","enrollment":18},{"nctId":"NCT00721617","phase":"NA","title":"FFA Hypertension and Inflammation in Lean and Obese Subjects","status":"COMPLETED","sponsor":"Emory University","startDate":"2009-04","conditions":"Diabetes, Hypertension, Obesity","enrollment":12},{"nctId":"NCT01152242","phase":"PHASE1","title":"Pharmacodynamic and Pharmacokinetic Variability of a Basal Insulin (0000-168)","status":"COMPLETED","sponsor":"Merck Sharp & Dohme LLC","startDate":"2010-08","conditions":"Diabetes","enrollment":36},{"nctId":"NCT00582309","phase":"NA","title":"Comparative Trial Between 3 Types of Insulin Infusion Protocols","status":"COMPLETED","sponsor":"University of New Mexico","startDate":"2007-08","conditions":"Hyperglycemia","enrollment":151},{"nctId":"NCT00460499","phase":"PHASE1","title":"Improving Outcomes In Diabetic Patients During CABG Surgery By Optimizing Glycemic Control","status":"COMPLETED","sponsor":"American Heart Association","startDate":"2004-07","conditions":"Glycemic Control","enrollment":250},{"nctId":"NCT01055340","phase":"PHASE1","title":"A Study That Will Evaluate Ketogenesis and Glucose-Dependent Insulin Secretion Methodologies in Healthy Male Subjects (MK-0000-159)(COMPLETED)","status":"COMPLETED","sponsor":"Merck Sharp & Dohme LLC","startDate":"2010-04","conditions":"Obesity","enrollment":12},{"nctId":"NCT01361594","phase":"PHASE3","title":"Intensive Insulin Therapy in Patients Undergoing Coronary Artery Bypass Surgery","status":"COMPLETED","sponsor":"Emory University","startDate":"2011-06","conditions":"Diabetes","enrollment":338},{"nctId":"NCT01340040","phase":"PHASE1","title":"Dose-escalation Study to Assess Safety, Tolerability and Pharmacokinetics of MEDI-573 in Japanese Subjects","status":"COMPLETED","sponsor":"AstraZeneca","startDate":"2011-07","conditions":"Cancer, Advanced Solid Malignancies","enrollment":10},{"nctId":"NCT00625040","phase":"","title":"Incretin Physiology and Beta-cell Function Before and After Weight-loss","status":"TERMINATED","sponsor":"Glostrup University Hospital, Copenhagen","startDate":"2008-01","conditions":"Obesity","enrollment":10},{"nctId":"NCT01300260","phase":"PHASE1","title":"Effect of LY2189265 on Insulin Secretion in Response to Intravenous Glucose","status":"COMPLETED","sponsor":"Eli Lilly and Company","startDate":"2011-02","conditions":"Diabetes Mellitus, Type 2","enrollment":32},{"nctId":"NCT00645827","phase":"NA","title":"Use of an Insulin Infusion Conversion Equation (IICE) to Control Blood Glucose in Hospitalized Patients","status":"COMPLETED","sponsor":"Emory University","startDate":"2008-01","conditions":"Glucose, Blood","enrollment":78}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":80,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"marketed","status":"active","brandName":"IV insulin infusion","genericName":"IV insulin infusion","companyName":"Rush University Medical Center","companyId":"rush-university-medical-center","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Insulin binds to insulin receptors on cells to promote glucose uptake and utilization, lowering blood glucose levels. Used for Hyperglycemia in hospitalized patients, Diabetic ketoacidosis, Hyperglycemic hyperosmolar state.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":1,"withResults":1},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}